Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Loading...
Loading...

Gainers

  • Evelo Biosciences, Inc. EVLO jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.
  • ContraFect Corporation CFRX gained 87% to $2.4693. ContraFect said first patient was dosed in the Phase 1b/2 study of exebacase in patients with chronic prosthetic joint infections of the knee.
  • Hillstream BioPharma, Inc. HILS jumped 56% to $1.10.
  • TOP Financial Group Limited TOP rose 53.7% to $10.33.
  • U Power Limited UCAR climbed 33.5% to $5.45 after declining around 27% on Wednesday.
  • Atomera Incorporated ATOM shares gained 23.6% to $6.45 after the company posted results for its first quarter. The company announced the execution of a commercial license agreement with STMicroelectronics (ST) that enables the latter to install Atomera's Mears Silicon Technology into its facilities.
  • OMNIQ Corp. OMQS climbed 20.8% to $5.47.
  • Vapotherm, Inc. VAPO rose 19.4% to $0.5001.
  • Helen of Troy Limited HELE shares gained 19.1% to $97.39 after the company announced better-than-expected Q4 results.
  • Nuburu, Inc. BURU gained 19% to $1.13.
  • Bel Fuse Inc. BELFB rose 18.3% to $36.25 following better-than-expected quarterly results.
  • Immuron Limited IMRN gained 16.4% to $2.23.
  • CXApp Inc. CXAI climbed 16% to $10.74.
  • Mainz Biomed N.V. MYNZ gained 15.6% to $3.92.
  • Accuray Incorporated ARAY jumped 15% to $3.1050 after the company reported better-than-expected Q3 EPS and sales results.
  • LianBio LIAN rose 14.7% to $2.26. LianBio announced topline results from the Phase 3 EXPLORER-CN trial investigating mavacamten for Chinese patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM).
  • Meta Platforms, Inc. META climbed 14.3% to $239.64 as the company reported better-than-expected Q1 results and also announced an increase in active users.
  • Immix Biopharma, Inc. IMMX gained 14.1% to $2.13 after Nexcella, an Immix Biopharma subsidiary, disclosed positive 58-patient NXC-201 clinical data.
  • GRI Bio, Inc. GRI gained 14.1% to $6.79.
  • Goosehead Insurance, Inc GSHD jumped 13.8% to $61.15 following upbeat quarterly results.
  • Overstock.com, Inc. OSTK rose 13.7% to $20.54 following strong quarterly results.
  • Ardagh Metal Packaging S.A. AMBP gained 13.5% to $3.93 following Q1 results.
  • Materialise NV MTLS gained 13% to $8.80 as the company posted upbeat Q1 results and named Koen Berges as CFO.
  • Cimpress plc CMPR jumped 12.4% to $48.72 following strong quarterly sales.
  • Hasbro, Inc. HAS gained 10.8% to $57.00 after the company reported better-than-expected Q1 sales results and reiterated FY23 adjusted EPS guidance above the estimate.
  • Mangoceuticals, Inc MGRX surged 10.7% to $1.3418 after dropping around 33% on Wednesday. Mangoceuticals recently commenced online sales campaign with DojoLabs Group.
  • Getaround, Inc. GETR climbed 9.9% to $0.4999. Getaround received continued listing standard notice from NYSE related to delayed filing of Form 10-K.
  • Kaiser Aluminum Corporation KALU gained 9.7% to $63.82 following Q1 results.
  • OpGen, Inc. OPGN gained 6% to $0.88 after the company said its German subsidiary Curetis GmbH has met the remaining key milestones under the initial research and development collaboration agreement with FIND.

Losers

  • Baudax Bio, Inc. BXRX fell 52.5% to $0.8406 after the company reported the pricing of $4 million public offering.
  • Impinj, Inc. PI dropped 35.2% to $87.71 after the company reported mixed Q1 results and issued weak guidance.
  • 4D Molecular Therapeutics, Inc. FDMT shares fell 31.1% to $14.18. 4DMT presented interim data from intravitreal 4D-150 Phase 1/2 PRISM clinical trial in patients with wet AMD at ARVO 2023.
  • Aspen Technology, Inc. AZPN fell 25% to $173.76 after the company posted downbeat Q3 results and issued weak FY23 forecast.
  • Mobileye Global Inc. MBLY dropped 22% to $33.58 after the company lowered FY23 revenue guidance below estimates.
  • Crown ElectroKinetics Corp. CRKN fell 20.6% to $0.1206. Crown Electrokinetics recently issued a letter to shareholders.
  • Satixfy Communications Ltd. SATX dropped 19.8% to $0.8101.
  • PROCEPT BioRobotics Corporation PRCT fell 19.2% to $28.89 following wider-than-expected Q1 loss.
  • Crocs, Inc. CROX fell 18.5% to $120.35 after the company reported Q1 earnings results and after the company issued Q2 guidance.
  • ETAO International Co., Ltd. ETAO shares dropped 18.3% to $0.96 after gaining around 57% on Wednesday.
  • NETGEAR, Inc. NTGR dipped 18.1% to $13.77 following weak quarterly results.
  • Ideanomics, Inc. IDEX fell 17.2% to $0.0227 after dropping around 22% on Wednesday.
  • Kuke Music Holding Limited KUKE dropped 16.9% to $0.60.
  • Wolfspeed, Inc. WOLF fell 16.2% to $48.11 after the company issued weak Q4 guidance.
  • Avinger, Inc. AVGR fell 15.5% to $0.54.
  • MaxLinear, Inc. MXL dipped 15.5% to $24.78 after the company issued weak Q2 guidance.
  • IN8bio, Inc. INAB fell 13.3% to $1.6902. IN8bio announced oral presentation of new INB-200 Phase 1 data in glioblastoma to be presented at 2023 ASCO Annual Meeting.
  • H&E Equipment Services, Inc. HEES declined 12% to $36.36 following Q1 results.
  • Align Technology, Inc. ALGN fell 11.7% to $312.85 after the company reported Q1 financial results and issued guidance.
  • Opera Limited OPRA dropped 11.6% to $10.04 following Q1 results.
  • Sonic Automotive, Inc. SAH gained 11.3% to $46.28 following weak quarterly results.
  • American Rebel Holdings, Inc. AREB shares fell 11% to $0.1371 after gaining around 14% on Wednesday.
  • National Energy Services Reunited Corp. NESR dipped 11% to $2.94 after the company announced it was not able to file its Annual Report on Form 20-F for its fiscal year ended December 31, 2021 with the SEC.
  • Clearmind Medicine Inc. CMND fell 10.5% to $0.62. CONMED said it sees FY23 EPS of $3.30 to $3.50 and revenue of $1.205 billion to $1.250 billion.
  • Morningstar, Inc. MORN dropped 9.3% to $172.95 following Q1 results.
  • AbbVie Inc. ABBV dropped 8.5% to $147.95 after the company reported Q1 financial results and issued FY23 guidance.
  • Mobiquity Technologies, Inc. MOBQ fell 8.4% to $0.1718 after jumping 22% on Wednesday. Mobility Technologies recently announced its AI-powered ad targeting technology.
  • STMicroelectronics N.V. STM shares dropped 8.4% to $42.37 after reporting Q1 results.

Now Read This: Top 5 Health Care Stocks That Could Sink Your Portfolio This Quarter

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: NewsPenny StocksSmall CapIntraday UpdateMarketsMoversTrading IdeasMid-Day MoversTop Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...